TruScreen

TruScreen (NZX/ASX:TRU) provides a portable real-time cervical cancer screening solution $TRU

[TruScreen @_truscreen]

TruScreen (NZX/ASX:TRU) is an Australia & New Zealand based medical device company that has developed an AI-enabled device that can detect precancerous & cancerous cervical changes in real-time via optical & electrical measurements of cervical tissue https://t.co/hqCbCosesK $TRU

[TruScreen @_truscreen]

Last days to register for TruScreen International Medical virtual symposium 2023.
Register here: https://t.co/8R7T2sGYTt

[TruScreen @_truscreen]

TruScreen Group Limited (NZX/ASX: TRU) is pleased to provide its unaudited financial results for the six months to 30 September 2023 (1H FY24). TruScreen reports according to the New Zealand financial year.

Read the full announcement: https://t.co/RDvc3u72Y9

[TruScreen @_truscreen]

Truscreen Group Limited (NZX/ASX:TRU) is pleased to confirm a further purchase order
from Zimbabwe for SUS (single use sensor) with a gross sales value of approximately NZ$300,000.
Read the full announcement: https://t.co/6AxxrIubhb

[TruScreen @_truscreen]

TruScreen invites Doctors and Healthcare Professionals worldwide to our 2023 International Medical Virtual Symposium, highlighting the latest data and experiences from a panel of leading global experts. Register here: https://t.co/8R7T2sHwJ1

[TruScreen @_truscreen]

Truscreen Group Limited (NZX/ASX:TRU) is pleased to report a 33% growth in H1 FY24 product sales and a 28% growth in sales of Single Use Disposable Sensors (SUS) sales against the same period last year.
Read the full announcement: https://t.co/YxAxrEFOk9

[TruScreen @_truscreen]

Pitt Street Research has just published an update on TruScreen Group Limited, following an outstanding sales growth this financial year. Read the full report: https://t.co/GVhgMsKh0s

[TruScreen @_truscreen]

TruScreen Group Limited (NZX/ASX:TRU) is pleased to report that the Dr Sulaiman Al-Habib Medical Group, has installed the first tranche of four TruScreen devices for commercial use, for the screening of cervical cancer in Saudi Arabia.
Read more: https://t.co/E4k9y1PeIp

[TruScreen @_truscreen]

TruScreen (NZX/ASX:TRU) held its Annual Shareholders Meeting in Auckland today. | View the CEO’s presentation: https://t.co/G2AvSHcMXd

[TruScreen @_truscreen]

TruScreen (NZX/ASX:TRU) is pleased to provide a copy of the Meeting Results.
All resolutions were passed by a poll of present and registered proxy shareholders.| View a record of the vote: https://t.co/z4VTORscTv

[TruScreen @_truscreen]

Adapting to the future: TruScreen Advances Toward MDR Compliance. Our commitment to meeting MDR criteria is unwavering, ensuring our technology remains competitive and trusted as a leading medical device. Full regulatory update: https://t.co/85DUweemXs

[TruScreen @_truscreen]

Our recent visit to China yielded fruitful discussions with our Chinese Distributor. This visit aimed to synergise efforts, ensuring mutual success and impactful provision in China. Read more https://t.co/3S4zq7AvXJ

[TruScreen @_truscreen]

The TruScreening program in Zimbabwe has resumed with remarkable momentum, bringing hope to remote and under-served communities. Together, we're working towards a healthier future. | Read more: https://t.co/ofkLCk3QhM

[TruScreen @_truscreen]

Strengthening Collaborations in Vietnam: TruScreen's Beata Edling & Jerry Tan recently travelled to Vietnam to better understand the local market and set the stage for the coming period of growth. Read more: https://t.co/1L6sw77rnS

[TruScreen @_truscreen]

Promoting women's health is vital for sustainable economies. Impressed by discussions at the 13th APEC High-Level Meeting on Health and the Economy. TruScreen stands with the APEC Roadmap for Cervical Cancer Prevention, yet only 24% of economies meet WHO's 70% screening target.

[TruScreen @_truscreen]

TruScreen (NZX/ASX:TRU) is pleased to provide a copy of its August 2023 Stakeholder Newsletter. https://t.co/8wr8JwtT6H

[TruScreen @_truscreen]

TruScreen (NZX/ASX:TRU) is pleased to report a 100% growth in sales over the same quarter year on year and a 73% growth in sales of Single Use Sensor for the same period. | Read the announcement: https://t.co/UotE5ermL7

[TruScreen @_truscreen]

TruScreen (NZX/ASX: TRU) is pleased to advise that the CSCCP Cervical Cancer Screening Guideline, recognising the TruScreen technology, was published in the July edition of CSCCP’s journal. | NZX/ASX Announcement: https://t.co/uywgDQOopT

[TruScreen @_truscreen]

TruScreen (NZX/ASX: TRU), advises that its Annual Meeting will be held in the Boardroom of Link Market Services and online on Tuesday 29 August 2023. | NZX/ASX Announcement: https://t.co/BPkuRqamxg

[TruScreen @_truscreen]

TruScreen Group (NZX/ASX:TRU) has released its Annual Report for the financial year ended 31 March 2023.
Read the full report on our website: https://t.co/Nd6RYXLwDX

[TruScreen @_truscreen]

TruScreen (NZX/ASX:TRU) technology has been endorsed in CSCCP’s China Cervical Cancer Screening Management Guideline, one of the most important specialist medical clinical guidelines governing management of cervical cancer | https://t.co/7rHuQp1Ih6